✦ LIBER ✦

Thrombopoietic Agents for the Treatment of Persistent and Chronic Immune Thrombocytopenia in Children

✍ Scribed by Ramaswamy, Kavitha; Hsieh, Loan; Leven, Emily; Thompson, Michaela V.; Nugent, Diane; Bussel, James B.

Book ID: 124091618
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 927 KB
Volume: 165
Category: Article
ISSN: 1097-6833
DOI: 10.1016/j.jpeds.2014.03.060

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Overview of Thrombopoietic Agents in the

Overview of Thrombopoietic Agents in the Treatment of Thrombocytopenia

✍ Kobos, Rachel; Bussel, James B. 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 539 KB

Treatment options for chronic immune (id

Treatment options for chronic immune (idiopathic) thrombocytopenia purpura in children

✍ Michael D Tarantino 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 671 KB

Role of growth factors and thrombopoieti

Role of growth factors and thrombopoietic agents in the treatment of chronic hepatitis C

✍ Hans L. Tillmann; Keyur Patel; John G. McHutchison 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 374 KB

An analysis of outcomes and treatment co

An analysis of outcomes and treatment costs for children undergoing splenectomy for chronic immune thrombocytopenia purpura

✍ Natalie R. Gwilliam; David A. Lazar; Mary L. Brandt; Donald H. Mahoney Jr; David 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Cost Effectiveness of Romiplostim for th

Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland

✍ Dawn Lee, Patrick Thornton, Alexander Hirst… 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 518 KB

Vinblastine in the treatment of children

Vinblastine in the treatment of children and adolescents with refractory immune thrombocytopenia

✍ Brice Fresneau; Arnaud Petit; Mary-France Courcoux; Marie-Dominique Tabone; Anne 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 774 KB

Childhood immune thrombocytopenia (ITP) has a favorable outcome in most cases but severe bleeding may occur, mostly in children with very low platelet counts. Although first-line therapies are well defined, management of refractory ITP is not consensual. Vinblastine (VBL) is one second-line treatmen